针对免疫无塑性贫血的自主调节性T细胞的I期试验

Nazia Matto1, Shreyans Gandhi2, Marta Rzepkowska1

  • 1Department of Haematology Medicine, School of Cancer and Pharmaceutical Sciences, SGDP Centre, Denmark Hill, Kings College London, London.

Haematologica
|February 26, 2026
PubMed
概括

调节性T细胞 (Tregs) 疗法对于无形性贫血 (AA) 患者来说是安全的和可扩展的. 这种方法可能有助于恢复免疫平衡,并诱导那些对标准治疗无反应的人的临床反应.